Skip to main content
Top
Published in: AIDS Research and Therapy 1/2023

Open Access 01-12-2023 | Human Immunodeficiency Virus | Research

Biomedical association analysis between G2/M checkpoint genes and susceptibility to HIV-1 infection and AIDS progression from a northern chinese MSM population

Authors: Jiawei Wu, Lidan Xu, Bangquan Liu, Wenjing Sun, Yuanting Hu, Yi Yang, Keer Guo, Xueyuan Jia, Haiming Sun, Jie Wu, Yun Huang, Wei Ji, Songbin Fu, Yuandong Qiao, Xuelong Zhang

Published in: AIDS Research and Therapy | Issue 1/2023

Login to get access

Abstract

Background

MSM are at high risk of HIV infection. Previous studies have shown that the cell cycle regulation plays an important role in HIV-1 infection, especially at the G2/M checkpoint. ATR, Chk1, Cdc25C and CDK1 are key genes of G2/M checkpoint. However, the association between SNPs of these genes and susceptibility to HIV-1 infection and AIDS progression remains unknown.

Methods

In this study, 42 tSNPs from the above four G2/M checkpoint genes were genotyped in 529 MSM and 529 control subjects from northern China to analyze this association.

Results

The results showed that rs34660854 A and rs75368165 A in ATR gene and rs3756766 A in Cdc25C gene could increase the risk of HIV-1 infection (P = 0.049, OR = 1.234, 95% CI 1.001–1.521; P = 0.020, OR = 1.296, 95% CI 1.042–1.611; P = 0.011, OR = 1.392, 95% CI 1.080–1.794, respectively), while Chk1 rs10893405 (P = 0.029, OR = 1.629, 95% CI 1.051–2.523) were significantly associated with AIDS progression. Besides, rs34660854 (P = 0.019, OR = 1.364, 95% CI 1.052–1.769; P = 0.022, OR = 1.337, 95% CI 1.042–1.716, under Codominant model and Dominant model, respectively) and rs75368165 (P = 0.006, OR = 1.445, 95% CI = 1.114–1.899; P = 0.007, OR = 1.418, 95% CI 1.099–1.831, under Codominant model and Dominant model, respectively) in ATR gene, rs12576279 (P = 0.013, OR = 0.343, 95% CI 0.147-0.800; P = 0.048, OR = 0.437, 95% CI 0.192–0.991, under Codominant model and Dominant model, respectively) and rs540436 (P = 0.012, OR = 1.407, 95% CI 1.077–1.836; P = 0.021, OR = 1.359, 95% CI 1.048–1.762, under Codominant model and Dominant model, respectively) in Chk1 gene, rs3756766 (P = 0.013, OR = 1.455, 95% CI 1.083–1.954; P = 0.009, OR = 1.460, 95% CI 1.098–1.940, under Codominant model and Dominant model, respectively) in Cdc25C gene and rs139245206 (P = 0.022, OR = 5.011, 95% CI 1.267–19.816; P = 0.020, OR = 5.067, 95% CI 1.286–19.970, under Codominant model and Recessive model, respectively) in CDK1 gene were significantly associated with HIV-1 infection under different models.

Conclusions

We found that genetic variants of G2/M checkpoint genes had a molecular influence on the occurrence of HIV-1 infection and AIDS progression in a northern Chinese MSM population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hussein M, Molina MA, Berkhout B, Herrera-Carrillo E. A CRISPR-Cas cure for HIV/AIDS. Int J Mol Sci Jan 13 2023;24(2). Hussein M, Molina MA, Berkhout B, Herrera-Carrillo E. A CRISPR-Cas cure for HIV/AIDS. Int J Mol Sci Jan 13 2023;24(2).
2.
go back to reference Guilamo-Ramos V, Thimm-Kaiser M, Benzekri A, et al. Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV/AIDS pandemic and emerging infectious disease outbreaks. Lancet Infect Dis Oct. 2021;21(10):e326–33.CrossRef Guilamo-Ramos V, Thimm-Kaiser M, Benzekri A, et al. Nurses at the frontline of public health emergency preparedness and response: lessons learned from the HIV/AIDS pandemic and emerging infectious disease outbreaks. Lancet Infect Dis Oct. 2021;21(10):e326–33.CrossRef
3.
go back to reference Giacinti C, Giordano A. RB and cell cycle progression. Oncogene Aug. 2006;28(38):5220–7.CrossRef Giacinti C, Giordano A. RB and cell cycle progression. Oncogene Aug. 2006;28(38):5220–7.CrossRef
4.
go back to reference Wiman KG, Zhivotovsky B. Understanding cell cycle and cell death regulation provides novel weapons against human diseases. J Intern Med May. 2017;281(5):483–95.CrossRef Wiman KG, Zhivotovsky B. Understanding cell cycle and cell death regulation provides novel weapons against human diseases. J Intern Med May. 2017;281(5):483–95.CrossRef
5.
go back to reference Barnum KJ, O’Connell MJ. Cell cycle regulation by checkpoints. Methods in molecular biology (Clifton N J). 2014;1170:29–40.CrossRefPubMed Barnum KJ, O’Connell MJ. Cell cycle regulation by checkpoints. Methods in molecular biology (Clifton N J). 2014;1170:29–40.CrossRefPubMed
6.
go back to reference Luo Q, Guo H, Kuang P, et al. Sodium Fluoride Arrests Renal G2/M phase cell-cycle progression by activating ATM-Chk2-P53/Cdc25C signaling pathway in mice. Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol. 2018;51(5):2421–33.CrossRef Luo Q, Guo H, Kuang P, et al. Sodium Fluoride Arrests Renal G2/M phase cell-cycle progression by activating ATM-Chk2-P53/Cdc25C signaling pathway in mice. Cell Physiol biochemistry: Int J experimental Cell Physiol Biochem Pharmacol. 2018;51(5):2421–33.CrossRef
7.
go back to reference Brown EJ, Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes & development Mar. 2003;1(5):615–28.CrossRef Brown EJ, Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes & development Mar. 2003;1(5):615–28.CrossRef
8.
go back to reference Koniaras K, Cuddihy AR, Christopoulos H, Hogg A, O’Connell MJ. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene Nov. 2001;8(51):7453–63.CrossRef Koniaras K, Cuddihy AR, Christopoulos H, Hogg A, O’Connell MJ. Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene Nov. 2001;8(51):7453–63.CrossRef
9.
go back to reference Nilsson I, Hoffmann I. Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res. 2000;4:107–14.CrossRefPubMed Nilsson I, Hoffmann I. Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res. 2000;4:107–14.CrossRefPubMed
10.
go back to reference Zhao RY, Elder RT. Viral infections and cell cycle G2/M regulation. Cell Res Mar. 2005;15(3):143–9.CrossRef Zhao RY, Elder RT. Viral infections and cell cycle G2/M regulation. Cell Res Mar. 2005;15(3):143–9.CrossRef
11.
go back to reference Sakai K, Barnitz RA, Chaigne-Delalande B, Bidere N, Lenardo MJ. Human immunodeficiency virus type 1 vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrest. Virol J May. 2011;11:8:219.CrossRef Sakai K, Barnitz RA, Chaigne-Delalande B, Bidere N, Lenardo MJ. Human immunodeficiency virus type 1 vif causes dysfunction of Cdk1 and CyclinB1: implications for cell cycle arrest. Virol J May. 2011;11:8:219.CrossRef
12.
go back to reference He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol Nov. 1995;69(11):6705–11.CrossRef He J, Choe S, Walker R, Di Marzio P, Morgan DO, Landau NR. Human immunodeficiency virus type 1 viral protein R (vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J Virol Nov. 1995;69(11):6705–11.CrossRef
13.
go back to reference Goh WC, Manel N, Emerman M. The human immunodeficiency virus vpr protein binds Cdc25C: implications for G2 arrest. Virol Jan. 2004;5(1):337–49.CrossRef Goh WC, Manel N, Emerman M. The human immunodeficiency virus vpr protein binds Cdc25C: implications for G2 arrest. Virol Jan. 2004;5(1):337–49.CrossRef
14.
go back to reference Iijima K, Kobayashi J, Ishizaka Y. Structural alteration of DNA induced by viral protein R of HIV-1 triggers the DNA damage response. Retrovirology Jan. 2018;16(1):8.CrossRef Iijima K, Kobayashi J, Ishizaka Y. Structural alteration of DNA induced by viral protein R of HIV-1 triggers the DNA damage response. Retrovirology Jan. 2018;16(1):8.CrossRef
15.
go back to reference Izumi T, Io K, Matsui M, et al. HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication. Proc Natl Acad Sci United States Am Nov. 2010;30(48):20798–803.CrossRef Izumi T, Io K, Matsui M, et al. HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication. Proc Natl Acad Sci United States Am Nov. 2010;30(48):20798–803.CrossRef
16.
go back to reference Li Y, Chen YL, Xie YT, et al. Association study of germline variants in CCNB1 and CDK1 with breast cancer susceptibility, progression, and survival among chinese Han women. PLoS ONE. 2013;8(12):e84489.CrossRefPubMedPubMedCentral Li Y, Chen YL, Xie YT, et al. Association study of germline variants in CCNB1 and CDK1 with breast cancer susceptibility, progression, and survival among chinese Han women. PLoS ONE. 2013;8(12):e84489.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Nan YL, Hu YL, Liu ZK, et al. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma. World J Gastroenterol Jun. 2016;28(24):5558–67.CrossRef Nan YL, Hu YL, Liu ZK, et al. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma. World J Gastroenterol Jun. 2016;28(24):5558–67.CrossRef
19.
go back to reference Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinf Jan. 2005;15(2):263–5. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinf Jan. 2005;15(2):263–5.
20.
go back to reference World Health Organization. WHO Case definitions of definitions of HIV for surveillance and revised clinical staging and inmunological classification of HIV-related disease in adults and children. ISBN 9789241595629. HIV/AIDS Programme; 2007. World Health Organization. WHO Case definitions of definitions of HIV for surveillance and revised clinical staging and inmunological classification of HIV-related disease in adults and children. ISBN 9789241595629. HIV/AIDS Programme; 2007.
21.
go back to reference Ariumi Y, Turelli P, Masutani M, Trono D. DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration. J Virol Mar. 2005;79(5):2973–8.CrossRef Ariumi Y, Turelli P, Masutani M, Trono D. DNA damage sensors ATM, ATR, DNA-PKcs, and PARP-1 are dispensable for human immunodeficiency virus type 1 integration. J Virol Mar. 2005;79(5):2973–8.CrossRef
22.
go back to reference Hemelaar J. The origin and diversity of the HIV-1 pandemic. Trends in molecular medicine Mar. 2012;18(3):182–92.CrossRef Hemelaar J. The origin and diversity of the HIV-1 pandemic. Trends in molecular medicine Mar. 2012;18(3):182–92.CrossRef
23.
go back to reference Elder RT, Yu M, Chen M, Zhu X, Yanagida M, Zhao Y. HIV-1 vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virol Sep. 2001;1(2):359–70.CrossRef Elder RT, Yu M, Chen M, Zhu X, Yanagida M, Zhao Y. HIV-1 vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Wee1 and Cdc25. Virol Sep. 2001;1(2):359–70.CrossRef
24.
go back to reference DeHart JL, Bosque A, Harris RS, Planelles V. Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation. J Virol Sep. 2008;82(18):9265–72.CrossRef DeHart JL, Bosque A, Harris RS, Planelles V. Human immunodeficiency virus type 1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation. J Virol Sep. 2008;82(18):9265–72.CrossRef
25.
go back to reference Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol reviews Oct. 2001;14(4):753–77. table of contents.CrossRef Lawn SD, Butera ST, Folks TM. Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol reviews Oct. 2001;14(4):753–77. table of contents.CrossRef
26.
go back to reference Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat reviews Mol cell biology Aug. 2008;9(8):616–27.CrossRef Cimprich KA, Cortez D. ATR: an essential regulator of genome integrity. Nat reviews Mol cell biology Aug. 2008;9(8):616–27.CrossRef
27.
go back to reference Xu B, Kim ST, Lim DS, Kastan MB. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell biology Feb. 2002;22(4):1049–59.CrossRef Xu B, Kim ST, Lim DS, Kastan MB. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol Cell biology Feb. 2002;22(4):1049–59.CrossRef
28.
go back to reference Zhang M, Qureshi AA, Guo Q, Han J. Genetic variation in DNA repair pathway genes and melanoma risk. DNA repair Jan. 2011;2(1):111–6.CrossRef Zhang M, Qureshi AA, Guo Q, Han J. Genetic variation in DNA repair pathway genes and melanoma risk. DNA repair Jan. 2011;2(1):111–6.CrossRef
29.
go back to reference Wang K, Ye Y, Xu Z, et al. Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a chinese Han population. Cancer Genet Cytogenet Jul. 2010;1(1):40–6.CrossRef Wang K, Ye Y, Xu Z, et al. Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a chinese Han population. Cancer Genet Cytogenet Jul. 2010;1(1):40–6.CrossRef
30.
go back to reference Durocher F, Labrie Y, Soucy P, et al. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk french canadian breast/ovarian cancer families. BMC cancer Sep. 2006;29:6:230.CrossRef Durocher F, Labrie Y, Soucy P, et al. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk french canadian breast/ovarian cancer families. BMC cancer Sep. 2006;29:6:230.CrossRef
31.
go back to reference Tort F, Hernandez S, Bea S, et al. Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms. Leuk Jan. 2005;19(1):112–7. Tort F, Hernandez S, Bea S, et al. Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms. Leuk Jan. 2005;19(1):112–7.
32.
go back to reference Bertoni F, Codegoni AM, Furlan D, Tibiletti MG, Capella C, Broggini M. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. Genes chromosomes & cancer Oct. 1999;26(2):176–80.CrossRef Bertoni F, Codegoni AM, Furlan D, Tibiletti MG, Capella C, Broggini M. CHK1 frameshift mutations in genetically unstable colorectal and endometrial cancers. Genes chromosomes & cancer Oct. 1999;26(2):176–80.CrossRef
33.
go back to reference Solyom S, Pylkas K, Winqvist R. Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in finnish breast cancer families. Familial cancer Dec. 2010;9(4):537–40.CrossRef Solyom S, Pylkas K, Winqvist R. Screening for large genomic rearrangements of the BRIP1 and CHK1 genes in finnish breast cancer families. Familial cancer Dec. 2010;9(4):537–40.CrossRef
34.
go back to reference Jinno S, Suto K, Nagata A, et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J Apr. 1994;1(7):1549–56.CrossRef Jinno S, Suto K, Nagata A, et al. Cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J Apr. 1994;1(7):1549–56.CrossRef
35.
go back to reference Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nat Nov. 2000;23(6811):433–9.CrossRef Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nat Nov. 2000;23(6811):433–9.CrossRef
36.
go back to reference Kristjansdottir K, Rudolph J. Cdc25 phosphatases and cancer. Chem biology Aug. 2004;11(8):1043–51.CrossRef Kristjansdottir K, Rudolph J. Cdc25 phosphatases and cancer. Chem biology Aug. 2004;11(8):1043–51.CrossRef
37.
go back to reference Doree M, Galas S. The cyclin-dependent protein kinases and the control of cell division. FASEB journal: official publication of the Federation of American Societies for Experimental Biology Nov. 1994;8(14):1114–21.CrossRef Doree M, Galas S. The cyclin-dependent protein kinases and the control of cell division. FASEB journal: official publication of the Federation of American Societies for Experimental Biology Nov. 1994;8(14):1114–21.CrossRef
38.
go back to reference Masui Y. Towards understanding the control of the division cycle in animal cells. Biochem cell biology = Biochimie et Biol cellulaire Oct-Nov. 1992;70(10–11):920–45.CrossRef Masui Y. Towards understanding the control of the division cycle in animal cells. Biochem cell biology = Biochimie et Biol cellulaire Oct-Nov. 1992;70(10–11):920–45.CrossRef
39.
go back to reference Dunphy WG, Kumagai A. The cdc25 protein contains an intrinsic phosphatase activity. Cell Oct. 1991;4(1):189–96.CrossRef Dunphy WG, Kumagai A. The cdc25 protein contains an intrinsic phosphatase activity. Cell Oct. 1991;4(1):189–96.CrossRef
40.
go back to reference Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiol Jan. 1990;1(1):43–6.CrossRef Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiol Jan. 1990;1(1):43–6.CrossRef
41.
go back to reference Green J, Britten N. Qualitative research and evidence based medicine. Bmj Apr. 1998;18(7139):1230–2.CrossRef Green J, Britten N. Qualitative research and evidence based medicine. Bmj Apr. 1998;18(7139):1230–2.CrossRef
Metadata
Title
Biomedical association analysis between G2/M checkpoint genes and susceptibility to HIV-1 infection and AIDS progression from a northern chinese MSM population
Authors
Jiawei Wu
Lidan Xu
Bangquan Liu
Wenjing Sun
Yuanting Hu
Yi Yang
Keer Guo
Xueyuan Jia
Haiming Sun
Jie Wu
Yun Huang
Wei Ji
Songbin Fu
Yuandong Qiao
Xuelong Zhang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
AIDS Research and Therapy / Issue 1/2023
Electronic ISSN: 1742-6405
DOI
https://doi.org/10.1186/s12981-023-00536-w

Other articles of this Issue 1/2023

AIDS Research and Therapy 1/2023 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.